Becton, Dickinson and Co. | BDX - Current Assets


Becton, Dickinson and Co. reported $8.14B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.69B 70M Jun/2026
Align Technology USD 2.66B 7.62M Jun/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Dentsply International USD 1.93B 83M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
J&J USD 59.77B 601M Jun/2026
Medtronic USD 24.39B 397M Jun/2026
Solventum Corp USD 3.74B 158M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Terumo JPY 906.6B 45.57B Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026